FDA
-
-
-
-
-
-
-
Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
-
-
-
-
-
-
-
DexCom adds AI meal logging to Stelo and G7 glucose monitors
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on DexCom (DXCM), PT $99, 'we believe the stock should be strong today'
-
-
-
-
-
-
-
RBC Capital: 'Opportunities Across MedTech Stocks'
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on DexCom (DXCM)
-
-
-
-
-
-
-
DexCom (DXCM) Announces FDA Clearance of Stelo Glucose Biosensor System
-
-
-
-
-
-
-
Synchron Appoints Andy Rasdal to Board of Directors
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

